SkinHealth Systems Inc. (SKIN) stock
SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.46−1.41 (-10.20%)
Close on Nov 18, 2026Market cap $1.62BP/E –Yield –
SkinHealth Systems revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
SkinHealth Systems's revenue for the twelve months ending Jun 30, 2026 was $290.05M, down 6.5% year over year. For fiscal 2025 it was $300.79M, down 10.0% from the year before. The highest annual figure on record is $397.99M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $300.79M | -10.0% |
| FY2024 | Dec 31, 2024 | $334.29M | -16.0% |
| FY2023 | Dec 31, 2023 | $397.99M | +8.8% |
| FY2022 | Dec 31, 2022 | $365.88M | +40.7% |
| FY2021 | Dec 31, 2021 | $260.09M | +118.4% |
| FY2020 | Dec 31, 2020 | $119.09M | -28.5% |
| FY2019 | Dec 31, 2019 | $166.62M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $72.11M | -7.8% |
| Q1 FY2026 | Mar 31, 2026 | $64.91M | -6.7% |
| Q4 FY2025 | Dec 31, 2025 | $82.37M | -1.3% |
| Q3 FY2025 | Sep 30, 2025 | $70.66M | -10.3% |
| Q2 FY2025 | Jun 30, 2025 | $78.19M | -13.7% |
| Q1 FY2025 | Mar 31, 2025 | $69.58M | -14.5% |
| Q4 FY2024 | Dec 31, 2024 | $83.50M | -13.8% |
| Q3 FY2024 | Sep 30, 2024 | $78.80M | -19.1% |
| Q2 FY2024 | Jun 30, 2024 | $90.59M | -22.9% |
| Q1 FY2024 | Mar 31, 2024 | $81.40M | -5.7% |
| Q4 FY2023 | Dec 31, 2023 | $96.82M | -1.3% |
| Q3 FY2023 | Sep 30, 2023 | $97.41M | +9.7% |
| Q2 FY2023 | Jun 30, 2023 | $117.48M | +13.5% |
| Q1 FY2023 | Mar 31, 2023 | $86.28M | +14.4% |
| Q4 FY2022 | Dec 31, 2022 | $98.13M | +26.0% |
| Q3 FY2022 | Sep 30, 2022 | $88.79M | +30.3% |
| Q2 FY2022 | Jun 30, 2022 | $103.54M | +55.7% |
| Q1 FY2022 | Mar 31, 2022 | $75.42M | +58.6% |
| Q4 FY2021 | Dec 31, 2021 | $77.89M | +105.6% |
| Q3 FY2021 | Sep 30, 2021 | $68.15M | +97.2% |
| Q2 FY2021 | Jun 30, 2021 | $66.51M | +371.2% |
| Q1 FY2021 | Mar 31, 2021 | $47.54M | – |
| Q4 FY2020 | Dec 31, 2020 | $37.88M | – |
| Q3 FY2020 | Sep 30, 2020 | $34.56M | – |
| Q2 FY2020 | Jun 30, 2020 | $14.12M | – |
See a number that looks wrong?